Kerecis Communications

Fish Skin Company Kerecis Named Iceland’s Fastest Growing Startup

• May 30th, 2017

Alvogen to Market Regenerative Fish Skin in Korea, Taiwan and Thailand

• April 21st, 2017

Fish Skin Wound Treatment Now Covered by Medicare in all 50 States

• April 6th, 2017

Kerecis Receives Funding from DoD to Develop Fish Skin Burn Treatment

• October 24th, 2016

Kerecis Introduces its Fish-Skin Wound Treatment to the Asian Market at Major Medical Congress

• October 18th, 2016

Kerecis to Present Results of Five Studies in the Desert Foot Conference

• October 17th, 2016

Comparative Study at a Podiatrist Facility in Indiana Estimates $65,000 Savings from Using Omega3-Rich Fish Skin for Diabetic Wound Treatment

• October 7th, 2016

Kerecis Wound-Treatment Product with Omega3 Fish Skin Now Eligible for Medicare Reimbursement in 45 States

• September 16th, 2016

FDA Clears Omega3-rich Fish Skin for Surgical Applications. Device Cleared for Bariatric, Gastric and Colorectal Surgeries

• September 13th, 2016

Studies Show That the Kerecis Fish Skin Reduces Infections and Preserves Tissue Viability

• August 15th, 2016

Kerecis Fish Skin Wound Treatment Available for the VA and Other Government Agencies. Listed on the Federal Supply Schedule (FSS)

• August 12th, 2016

Kerecis Fish-Skin Wound Treatment Now Eligible for Reimbursement in North Carolina, South Carolina, Virginia and West Virginia Coverage Provided by Medicare Administrative Contractor Palmetto GBA

• May 23rd, 2016

Kerecis One of Top 5 Most Innovative European Wound Companies in 2016

• May 11th, 2016

Application of Fish Skin to Open Wounds Improves Healing High-Impact Trial Results of Fish Skin Wound Treatment Presented at Major European Wound Conference

• May 10th, 2016

High-Impact Trial Results of Fish Skin Wound Treatment to Be Presented at SAWC Conference Multiple Poster Abstracts Demonstrate Efficacy of Fish Skin Wound Treatment When Compared to Alternative Technologies

• April 14th, 2016

Kerecis Fish Skin Wound Treatment to be Available for U.S. Military Veterans Will be listed on the Federal Supply Schedule (FSS) through MellingMedical

• April 4th, 2016

PolyMedics Innovations to Sell Kerecis Omega3-rich Fish-Skin Burn Treatment in the U.S.

• March 22nd, 2016

Kerecis Omega3 Fish Skin Wound Grafts Recruit Significantly More Cells than a Leading Amnion Membrane Wound Treatment Brand

• September 25th, 2015

Studies on the Kerecis Fish Skin Graft Show that the Product Recruits Stem Cells and Closes Wounds Significantly Faster than the Leading Competitive Product

• August 17th, 2015

Kerecis Founder and CEO Named Entrepreneur of the Year

• June 25th, 2015

Medical Fish Skin Company Kerecis and the US Navy Office of Naval Research to Develop New Treatments for Severely Injured Limbs

• April 30th, 2015

Fish Skin Helps Heal Human Wounds and Tissue Damage

• March 23rd, 2015

Medical Fish Skin Company Kerecis Receives Annual Innovation Through Knowledge Award From President of Iceland

• March 17th, 2015

Kerecis Establishes U.S. Presence and Names Chris Harte Chief Operating Officer

• February 26th, 2015

Lamed to Sell Fish-Skin Wound-Treatment Product in Germany, Austria and Switzerland

• January 30th, 2015

Kerecis Fish-Skin Treatment Receives Medicare “Q” Code

• November 12th, 2014

Kerecis Selected to Present at the Northern Prime Minister Meeting

• November 6th, 2014

Kerecis to Participate in the Military Health System Research Symposium, August 18 to 21

• August 14th, 2014

Kerecis to Present at NASDAQ OMX

• May 23rd, 2014

Kerecis to Participate in the Nordic Oncoplastic and Reconstructive Breast Surgeons’ Conference May 8-9

• May 5th, 2014

Fish-Skin Medical Company Completes Funding Round

• February 21st, 2014

Kerecis Receives U.S. Patent for Fish-Skin-Based Tissue Regeneration Technology

• February 13th, 2014

Does Fish Skin Reduce Scarring from Plastic Surgery?

• January 24th, 2014

FDA Clears Fish-Skin Technology to Heal Human Wounds

• November 7th, 2013

Kerecis Establishes Scientific Advisory Board of Leading Experts in Wound Care and Surgical Implants

• August 8th, 2013

New Board Members Join Kerecis

• June 17th, 2013

Kerecis Completes Successful Immunology Study

• May 3rd, 2013

Kerecis Completes US$ 1 Million Series A2 Funding

• April 26th, 2013

Kerecis Announces a Distribution Agreement with Medline Industries for the MariGen Omega3 Tissue-regeneration Technology

• January 31st, 2013

Follow-Up Study Demonstrates Safety and Efficacy of Omega3 Wound-Healing Treatment

• May 18th, 2012

Clinical Trial Demonstrates Safety and Efficacy of Wound-Healing Treatment

• October 6th, 2011

Minister of Industry Inaugurates Fish Skin Medical Device Facility

• September 26th, 2011

Kerecis to Present at IN3 East Investor Conference in Boston, June 21 – 23, 2011

• June 20th, 2011

Kerecis Completes Interim Financing

• May 24th, 2011

Kerecis Limited Receives ISO 13485:2003 Quality Management System Certification

• March 24th, 2011

Kerecis to Present at Investment Forums in London and New York

• November 3rd, 2010

Kerecis Announces New Directors Eythor Bender and Egill Masson

• October 8th, 2010

Research Collaboration Between Kerecis and ValaMed

• July 14th, 2010

Kerecis to Present at IN3 East Investor Conference in Boston, June 10 – 11, 2010

• June 9th, 2010

Kerecis Announces New VP of Science and Technology

• May 3rd, 2010